-
Disparities in COVID-19 Vaccination Uptake by Social Vulnerability Index: A US nationwide study
Mar 10, 2025, 14:00 PM -
Adverse Events: Does Experience Impact Preferences? A Review of the Literature
Mar 10, 2025, 14:00 PM -
Standardized Tools for Constructing DAGs - Advancing Causal Inference and Risk Assessment in Pharmaceutical Studies
Mar 10, 2025, 14:00 PM -
The Use of Social Media Listening to Collect Oncology-Specific Patient Experience Data: A Scoping Review
Mar 10, 2025, 14:00 PM -
Cost-per-Event Analysis of Risankizumab in Comparison to Ustekinumab for the Treatment of Patients With Moderate-to-Severe Crohn’s Disease in Brazil
Mar 10, 2025, 14:00 PM -
Variables Statistically Associated With Mental Health Among United States Adults With Asthma in the Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Assessing Differences in Clinical Burden Across Payers for Non-Obstructive Hypertrophic Cardiomyopathy
Mar 10, 2025, 14:00 PM -
Patient Value Assessment Using a Unified Measure Based on Data Envelopment Analysis: A Case Study
Mar 10, 2025, 14:00 PM -
Predicted Effectiveness of First- and Second-Line Treatment Sequences in Advanced or Recurrent Endometrial Cancer
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization of Adult Patients with Obesity Before vs. After GLP-1 Treatment in the United States Elective Outpatient Setting
Mar 10, 2025, 14:00 PM -
Economic and Health Care Resource Utilization (HCRU) Burden of Acute Myocardial Infarction (AMI) With or Without Systemic Inflammation in US Hospitals: A Real-World Study
Mar 10, 2025, 14:00 PM -
Market Access Challenges for Innovative Medications in Women's Health in Canada: Overview of the Past 20 Years
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization (HCRU) and Costs of Poly(ADP-ribose) Polymerase Inhibitors (PARPi) as First-Line Maintenance (1LM) Treatment for Ovarian Cancer (OC)
Mar 10, 2025, 14:00 PM -
Enhancing Early-Phase Trial Outcomes: The Value of Patient-Reported Treatment Tolerability
Mar 10, 2025, 14:00 PM -
Other Similar Measures? – How Different Really Are QALYs From Life Years, Health Years in Total, and Equal Value Life Years?
Mar 10, 2025, 14:00 PM -
HTA Assessments for Multipurpose Contrast Agents: Insights and Solutions to Formal HTA Challenges
Mar 10, 2025, 14:00 PM -
Suicidal Ideation in Patients Treated With Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis
Mar 10, 2025, 14:00 PM -
Work Productivity Losses of Systemic Lupus Erythematosus in a U.S. Commercially Insured Population
Mar 10, 2025, 14:00 PM -
Estimation of Drug Cost Reductions by Introducing formularies for An Employment-based Health Insurance Plan : A Simulation Using “Wellness-Star☆” Health Insurance Claims Database
Mar 10, 2025, 14:00 PM -
The Effect of the COVID-19 Pandemic on Influenza Vaccine Uptake by Pregnant Women in the US
Mar 10, 2025, 14:00 PM
